How many clinical trials are tracked of isotretinoin?

19 trials are tracked, 6 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Dermatology Ophthalmology Emergency Medicine Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

isotretinoin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of isotretinoin

19 trials tracked of isotretinoin: 9 in phase 3 or 4 and 6 with published results. The most-cited published study has 1812 citations.

19Trials tracked

9Phase 3 & 4

0Recruiting

6With published results

Phase distribution

Phase 4 3 Phase 3 6 Phase 2 9 Phase 1 1

Phase 3 Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Completed · 1,812 cited
Phase 3 Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Completed · 357 cited
Phase 3 Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma Completed · 128 cited
Phase 3 Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne Completed · 51 cited
Phase 4 ABSORICA in Patients With Severe Recalcitrant Nodular Acne Completed · 13 cited
Phase 4 Effects of Isotretinoin on CYP2D6 Activity Completed · 1 cited

Show 13 more trials

Phase 4 Isotretinoin for Proliferative Vitreoretinopathy Completed
Phase 3 Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne Completed
Phase 3 Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma Completed
Phase 2 A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis Completed
Phase 2 Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery Completed
Phase 2 ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma Completed
Phase 2 Podocyte Retinoids Completed
Phase 2 Therapy for Children With Advanced Stage Neuroblastoma Completed
Phase 2 Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma Completed
Phase 2 Weekly Isotretinoin Therapy Study Completed
Phase 2 Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme Completed
Phase 2 Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Completed
Phase 1 Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin Completed

Showing the 19 most-cited and recently-updated of 19 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.